Guías Clínicas 146 GUÍA CLÍNICA DE MANEJO Y TRATAMIENTO DE LA INFECCIÓN POR VIRUS DE LA HEPATITIS B - Ministerio de Salud, Chile con Infección por VIH. Libro del XXIV Congreso Chileno de Infectología 2007. 143.- Cohorte chilena de SIDA (SIDACHI-LE). Disponible en : http://www.sidachi-le. cl/. Accedido el 30/09/2009. 144.- Weber R, Sabin CA, Friss-Moller N, et al. Liver-Related Deaths in Persons Infected With the Human Immunode-ficiency Virus. Arch Intern Med 2006; 166: 1632-41. 145.- Bica I, McGovern B, Dhar R, et al. In-creasing mortality due to end-stage liver disease in patients with human immu-nodeficiency virus infection. Clin Infect Dis 2001 Feb 1; 32 (3): 492-7. 146.- Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multi-center Cohort Study (MACS). Lancet 2002; 360: 1921-6. 147.- Iloeje UH, Yang HI, Su J et al. Predic-ting cirrhosis risk based on the level of circulating hepatitis B viral load. Gas-troenterology 2006; 130: 678-86. 148.- Konopnicki D, Mocroft A, De Wit S. Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 2117-125. 149.- Tsui J, French A, Seaberg E, Augenbraun M, Nowicki M, Peters M, et al. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007; 45: 736-40. 150.- Liaw YF. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Antivir Ther 2006; 11:669-79. 151.- Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-In-fected Adults and Adolescents, June 18, 2008, Recommendations of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the HIV Medicine Associa-tion of the Infectious Diseases Society of America (HIVMA/IDSA), available at http://AIDSinfo.nih.gov. Accedido el 30/09/2009. 152.- Soriano V, Puotib M, Petersc M, Benhamoud Y, Sulkowskie M, et al. Care of HIV patients with chronic hepa-titis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008; 22: 1399-410. 153.- Gaglio PJ, Sterling R, Daniela E, Tedaldi E. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommenda-tions for therapy. Clin Infect Dis 2007; 45: 618-23. 154.- Arribas J, González J, Lorenzo A, Montero D, Ladrón D, Montes M, et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 2005; 19: 1361-5. 155.- Jardi R, Rodríguez F, Buti M, Costa X, Cortina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral geno-types and hepatitis B precore and basal core promoter mutations on viral replica-tive interference. Hepatology 2001; 34: 404-10. 156.- Raimondo G, Brunetto M, Pontisso P, Smedile A, Maina A, et al. longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B vi-rus/ hepatitis C virus-coinfected patients. Hepatology 2006; 43: 100-7. 157.- Martin-Carbonero L, Barreiro P, Jiménez-Galán G, García-Berriguete R, Núñez M, Ríos P, et al. Spontaneous clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. J Viral Hepat 2007; 14:392-5. 158.- Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C, et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 2004; 32: 144-8. 159.- Puoti M, Bruno R, Soriano V, Donato F, Gaeta G, Quinzan G, et al. Hepatocellu-lar carcinoma in HIV-infected patients: epidemiological features, clinical pre-sentation and outcome. AIDS 2004; 18: 2285-93. 160.- Zarski JP, Bohn B, Bastie A, et al. Characteristics of patients with dual infection by hepatitis B and C. J Hepatol 1998; 28: 27-33. 161.- Benvegnu L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 2442-8. 162.- Chen YC, Sheen IS, Chu CM, et al. Prognosis following spontaneous HB-sAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002; 123: 1084-9. 163.- Crockett SD, Keefe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 2005; 4: 13. 164.- Dai CY, Yu ML, Chuang WL, et al. Influence of hepatitis C virus on the pro-files of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001; 16: 636-40. 165.- Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68. 166.- Hui CK, Lie A, Au WY, et al. A long- term follow-up study on hepatitis B surface antigen-positivepatients uder-going allogeneic hematopoietic stem cell trasplantation. Blood 2005; 106: 464-9. 167.- Papatheodoridis GV, Manolakopoulos S, Archimandritis AJ. Current treatment indications and strategies in chronic he-patitis B infection. World J Gastro 2008; 14: 6902-10. 168.- Kohrt HE, Ouyang DL, Keeffe EB. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Clin Liver Dis 2007; 11: 965-91. 169.- Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68. 170.- Hui CK, Lie A, Au WY, et al. A long- term follow-up study on hepatitis B surface antigen-positivepatients uder-going allogeneic hematopoietic stem cell trasplantation. Blood 2005; 106: 464-9. 171.- Rakesh Aggarwal, Piyush Ranjan. Pre-venting and treating hepatitis B infec-tion. BMJ 2004; 329: 1080-6. 172.- Keeffe Emmet B. Hepatitis B: Explosion of new knowledge. Editorial. Gastroen-terology 2007; 133: 1718-21. 173.- Jonas Maureen M. Treatment of chronic hepatitis B in children. J Pediatr Gas-troenterol Nutr 2006; 43: S56-60. 174.- Hierro L. Consenso para el tratamiento de las hepatitis B y C. Virus de la hepa-titis B. Hepatitis B en niños y gestantes. Gastroenterología y Hepatología 2006; 29 (Supl 2): 72-5. Gastroenterol. latinoam 2010; Vol 21, Nº 2: 89-147
n1-2010
To see the actual publication please follow the link above